KOREA PHARMA Co., Ltd.
KOSDAQ-listed pharmaceutical company exporting to 17 countries, combining finished-drug manufacturing with CMO contract manufacturing.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 1985 and listed on the KOSDAQ in 2020, Korea Pharma is a pharmaceutical company specializing in CNS, gastrointestinal, cardiovascular, and antibacterial drugs. It manufactures and sells finished pharmaceuticals while also running a CMO business for solid dosage forms, oral liquids, topical liquids, and ointments, and has obtained EU GMP certification for its topical liquid/lotion products. As of 2025 it exported roughly KRW 2.2 billion worth of goods, registering and exporting around 60 self-manufactured products to 17 countries including Yemen, Myanmar, Vietnam, Nigeria, and Azerbaijan, and it also runs a domestic/overseas out-licensing business, having assigned a patent for an oral pharmaceutical composition containing choline alfoscerate to Daewoong Bio Co. in 2017.
Regulatory approvals
data.go.kr306 Korean MFDS drug approvals · 1985–2026
- MFDS drugQuety tab. 12.5mg2026-04-22Drug · Prescription · Approval202601183
- MFDS drugPharma tegoprazan 25mg2026-04-14Drug · Prescription · Approval202601071
- MFDS drugPharma tegoprazan 50mg2026-04-14Drug · Prescription · Approval202601072
- MFDS drugQuety tab. 50mg2026-03-17Drug · Prescription · Approval202600767
- MFDS drugAccrufer Cap.2025-11-05Drug · Prescription · Approval202502868
- MFDS drugOlzapex Tab. 2.5mg2025-07-30Drug · Prescription · Approval202501982
- MFDS drugPharma Naratriptan ODT 2.5mg(Naratriptan Hydrochloride)2024-12-09Drug · Prescription · Approval202402899
- MFDS drugPharma Mirtazapine Tab. 15mg2024-11-25Drug · Prescription · Approval202402770
- MFDS drugPharma Mirtazapine Tab. 7.5mg2024-11-25Drug · Prescription · Approval202402771
- MFDS drugPharma Mirtazapine Tab. 30mg2024-11-25Drug · Prescription · Approval202402772
- MFDS drugAratect Cap.100/5mg2024-09-27Drug · Prescription · Approval202402338
- MFDS drugpharma efinaconazole topical solution2024-08-13Drug · Prescription · Approval202401944
Show 68 more
- MFDS drugPharma Nicergoline tab. 30mg2024-06-28Drug · Prescription · Approval202401572
- MFDS drugPharma Desvenlafaxine ER Tab. 50mg2024-06-27Drug · Prescription · Approval202401555
- MFDS drugAlbix Tab. 20mg2024-06-26Drug · Prescription · Approval202401543
- MFDS drugAlbix Tab. 5mg2024-06-12Drug · Prescription · Approval202401435
- MFDS drugPharma Melatonin PR Tab. 2mg2024-05-30Drug · Prescription · Approval202401343
- MFDS drugPharma Desvenlafaxine ER Tab. 100mg2024-03-21Drug · Prescription · Approval202400587
- MFDS drugDivalpro ER Tab. 250mg2023-12-27Drug · Prescription · Approval202303449
- MFDS drugGinmacton Tab. 240mg2023-12-07Drug · OTC · Notification202303309
- MFDS drugDivalpro ER Tab. 500mg2023-11-08Drug · Prescription · Approval202303094
- MFDS drugPharma Empalow duo Tab. 12.5/1000mg2023-09-05Drug · Prescription · Approval202302642
- MFDS drugPharma Empalow duo Tab. 12.5/850mg2023-09-05Drug · Prescription · Approval202302643
- MFDS drugPharma Empalow duo Tab. 12.5/500mg2023-09-05Drug · Prescription · Approval202302644
- MFDS drugPharma doxepin Tab. 3mg2023-06-14Drug · Prescription · Notification202301840
- MFDS drugPharma doxepin Tab. 6mg2023-06-14Drug · Prescription · Notification202301841
- MFDS drugPharma Mini Mega soft Cap. 500mg2023-03-30Drug · Prescription · Approval202301078
- MFDS drugArabil tab. 1mg2023-03-09Drug · Prescription · Approval202300817
- MFDS drugCrirol Solution2023-01-04Drug · OTC · Approval202300044
- MFDS drugSalopram Tab. 15mg2022-11-28Drug · Prescription · Approval202204261
- MFDS drugPharma Trimebutine tab. 100mg(for export)(AMATASE Tab. 100mg)2022-10-27Drug · OTC · Notification202203922
- MFDS drugZero moo once Topical Solution (Terbinafine Hydrochloride)2022-10-13Drug · OTC · Notification202203820
- MFDS drugArabil tab. 2mg2022-09-08Drug · Prescription · Approval202203530
- MFDS drugRabetan tab. 20/800mg2022-06-30Drug · Prescription · Approval202202686
- MFDS drugAzelia tab. 16mg2022-06-13Drug · Prescription · Approval202202475
- MFDS drugPharma Empalow duo Tab. 5/850mg2022-04-26Drug · Prescription · Approval202201695
- MFDS drugPharma Empalow duo Tab. 5/500mg2022-04-26Drug · Prescription · Approval202201696
- MFDS drugPharma Empalow duo Tab. 5/1000mg2022-04-26Drug · Prescription · Approval202201697
- MFDS drugAzelia tab. 8mg2021-12-28Drug · Prescription · Approval202108119
- MFDS drugPharma Buspirone Tab. 10mg2021-09-15Drug · Prescription · Approval202106544
- MFDS drugPharma Buspirone Tab. 5mg2021-09-15Drug · Prescription · Approval202106545
- MFDS drugZero moo nail lacquer2021-07-29Drug · OTC · Notification202105619
- MFDS drugEsotan Tab. 20/800mg2021-06-18Drug · Prescription · Approval202104750
- MFDS drugVastia Tab 23mgRevoked2021-04-29Drug · Prescription · Approval202103492
- MFDS drugPharma eszopiclone Tab. 3mgRevoked2021-04-26Drug · Prescription · Approval202103385
- MFDS drugPharma eszopiclone Tab. 1mgRevoked2021-04-26Drug · Prescription · Approval202103386
- MFDS drugPharma eszopiclone Tab. 2mgRevoked2021-04-26Drug · Prescription · Approval202103387
- MFDS drugPharma Empalow Tab. 25mg2021-03-31Drug · Prescription · Approval202102824
- MFDS drugPharma Empalow Tab. 10mg2021-03-31Drug · Prescription · Approval202102825
- MFDS drugPharmaSodiumSeleniteRevoked2020-11-20Drug · Prescription · Notification202008067
- MFDS drugPharma Dapagliflozin Tab. 10mgRevoked2020-06-17Drug · Prescription · Approval202004455
- MFDS drugPharma Polaprezinc Tab2020-05-21Drug · Prescription · Approval202003716
- MFDS drugPharma Omega Soft Cap.2020-04-29Drug · Prescription · Approval202003229
- MFDS drugPharma Mosapride SR Tab. 15mg2020-04-28Drug · Prescription · Approval202003166
- MFDS drugPharma Lafutidine Tab.2020-04-24Drug · Prescription · Approval202002962
- MFDS drugPharma Sertraline Tab. 100mg2020-02-20Drug · Prescription · Approval202001212
- MFDS drugPharma Sertraline Tab. 25mg2020-02-20Drug · Prescription · Approval202001213
- MFDS drugPharma Rasagiline Tab. 0.5mgRevoked2020-01-31Drug · Prescription · Approval202000508
- MFDS drugTripgel Suspension (for export)2020-01-29Drug · OTC · Notification202000466
- MFDS drugPharma Tiropramide HCl Tab. 100mg2019-12-23Drug · Prescription · Approval201908586
- MFDS drugElpion Tab. 25mg2019-12-23Drug · Prescription · Approval201908596
- MFDS drugPharma Sertraline Tab. 50mg2019-12-03Drug · Prescription · Approval201908216
- MFDS drugPharma Tadalafil ODF. 5mgRevoked2019-11-12Drug · Prescription · Approval201907876
- MFDS drugPharma Tadalafil ODF. 20mgRevoked2019-11-12Drug · Prescription · Approval201907877
- MFDS drugPharma Tadalafil ODF. 10mgRevoked2019-11-12Drug · Prescription · Approval201907878
- MFDS drugPharma Rasagiline Tab.Revoked2019-10-22Drug · Prescription · Approval201907383
- MFDS drugNizatid Tab. 150mg2019-10-18Drug · Prescription · Approval201907346
- MFDS drugPlenvu Powder2019-08-09Drug · Prescription · Approval201905631
- MFDS drugPharma Theobromine Cap.Revoked2019-07-17Drug · Prescription · Notification201904793
- MFDS drugPharma Epinastine HCl Tab. 20mgRevoked2019-07-11Drug · Prescription · Approval201904682
- MFDS drugPharma Epinastine HCl Tab. 10mgRevoked2019-07-11Drug · Prescription · Approval201904683
- MFDS drugPhama Aceclofenac CR Tab.2019-06-20Drug · Prescription · Approval201904284
- MFDS drugPharma Irsogladine Maleate Tab. 2mgRevoked2019-05-31Drug · Prescription · Approval201903613
- MFDS drugPharma Irsogladine Maleate Tab. 4mgRevoked2019-05-31Drug · Prescription · Approval201903614
- MFDS drugMasafo SR Tab. 300mg2019-05-28Drug · Prescription · Approval201903474
- MFDS drugSalopram Tab. 5mg2019-05-21Drug · Prescription · Approval201903284
- MFDS drugPharma Roxithromycin Tab.Revoked2019-05-15Drug · Prescription · Approval201903154
- MFDS drugCholitirin Syrup2019-03-29Drug · Prescription · Approval201901953
- MFDS drugRopirino SR Tab. 2mgRevoked2019-03-07Drug · Prescription · Approval201901415
- MFDS drugRopirino SR Tab. 8mgRevoked2019-03-07Drug · Prescription · Approval201901423
Showing the 80 most recent of 306 records.
Clinical trials
data.go.kr47 MFDS clinical trial authorisations · 2012–2026 (Bioequivalence 41 · Phase 1 5 · Phase 2 1)
- Phase 1KP-25022026-03-23
2 trial sites
- Phase 1KP25012025-11-06
2 trial sites
- Phase 1KP24032025-03-31
2 trial sites
- Bioequivalence쿠에티정12.5밀리그램(쿠에티아핀푸마르산염)2024-06-04
2 trial sites
- BioequivalenceKP22032023-06-28
2 trial sites
- BioequivalenceKP22032023-06-23
2 trial sites
- BioequivalenceKP23012023-06-21
2 trial sites
- Bioequivalence아드펜정(펜디메트라진타르타르산염)2023-04-21
2 trial sites
- Bioequivalence파마프로시클리딘정2023-04-17
2 trial sites
- BioequivalenceKP21042022-09-29
2 trial sites
- Phase 1아크루퍼 (KP-01)2022-08-23
1 trial site
- Bioequivalence파마벤라팍신서방캡슐75밀리그램(벤라팍신염산염)2021-09-29
2 trial sites
Show 35 more
- Bioequivalence파피온서방정(부프로피온염산염)2021-06-29
2 trial sites
- Bioequivalence파피온서방정(부프로피온염산염)2021-06-25
2 trial sites
- Bioequivalence파마데스벤라팍신서방정100밀리그램(데스벤라팍신숙신산염일수화물)2021-03-16
2 trial sites
- Bioequivalence파마데스벤라팍신서방정100밀리그램(데스벤라팍신숙신산염일수화물)2021-03-15
2 trial sites
- Bioequivalence파마벤라팍신서방캡슐75밀리그램(벤라팍신염산염)2021-03-09
2 trial sites
- Bioequivalence임상시험계획승인신청중2021-03-02
2 trial sites
- Bioequivalence파마디발프로엑스서방정500밀리그램(디발프로엑스나트륨)2021-02-26
2 trial sites
- Bioequivalence파마벤라팍신서방캡슐75밀리그램(벤라팍신염산염)2021-02-23
2 trial sites
- Bioequivalence파마파록세틴씨알정25밀리그램(파록세틴염산염수화물)2021-02-18
2 trial sites
- Bioequivalence파마파록세틴씨알정25밀리그램(파록세틴염산염수화물)2021-01-27
2 trial sites
- Phase 1KP2012020-09-29
2 trial sites
- Bioequivalence올자펙스정10밀리그램(올란자핀)2020-05-26
2 trial sites
- Bioequivalence라베프린정20밀리그램(라베프라졸나트륨)2020-02-24
2 trial sites
- Bioequivalence파마파록세틴씨알정25밀리그램(파록세틴염산염수화물)2020-01-03
2 trial sites
- Bioequivalence파마파록세틴씨알정25밀리그램(파록세틴염산염수화물)2020-01-03
2 trial sites
- Bioequivalence아라빌정10밀리그램2019-11-06
2 trial sites
- Phase 2STH-KPO17012019-08-01
3 trial sites
- Bioequivalence리가린캡슐150mg(프레가발린)2018-12-27
2 trial sites
- Bioequivalence파마설트랄린염산염정50mg2018-10-08
2 trial sites
- Bioequivalence파마라사길린정(라사길린메실산염)2018-10-05
2 trial sites
- Bioequivalence프레토정(클로피도그렐황산염)2017-11-13
2 trial sites
- Bioequivalence바스티아정 23 밀리그램2017-08-16
2 trial sites
- Bioequivalence로피니롤서방정2mg(가칭)2017-03-09
2 trial sites
- Bioequivalence파마페노피브레이트콜린캡슐(가칭)(페노피브레이트콜린)2016-12-16
2 trial sites
- Bioequivalence파마블로난세린정8밀리그램(가칭)2016-10-05
2 trial sites
- Bioequivalence프레토정(클로피도그렐황산염)2015-12-03
2 trial sites
- Bioequivalence파마날트렉손정50mg(가칭)2015-10-23
2 trial sites
- Bioequivalence콜리티린정400밀리그램2015-06-04
2 trial sites
- Bioequivalence사로프람정20mg2015-04-28
2 trial sites
- Bioequivalence바스티아오디정10밀리그램2015-04-21
2 trial sites
- Bioequivalence쿠에티아핀푸마르산염2014-01-27
2 trial sites
- Bioequivalence파마주석산졸피뎀정2013-12-20
- Bioequivalence파마리팍시민정(리팍시민)2013-05-21
2 trial sites
- Bioequivalence알빅스정(염산메만틴)2013-01-04
- Bioequivalence파마필로카르핀정(필로카르핀염산염)2012-12-31
2 trial sites
R&D and key agreements
Source: DART corporate disclosure대구 첨복단지 신약연구센터 · 운영 중(2018년 7월 개소) · Plans specialized research in biologics, DDS-based improved new drugs, and contrast agents, plus national R&D projects
Companies in the same categoryPharma & CDMO
Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.
Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.
Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.
Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.
KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.
Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.
KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.
Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.
Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.
KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.
Founded and listed on KOSDAQ in 2015, Kolmar BioTech is a nonclinical CRO providing efficacy testing for anticancer and metabolic disease drug candidates.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition